Stock Scorecard



Stock Summary for Iradimed Corp (IRMD) - $90.27 as of 8/11/2026 1:48:59 PM EST

Total Score

15 out of 30

Safety Score

46 out of 100

Currently on the following lists
None
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for IRMD

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for IRMD

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for IRMD

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for IRMD

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for IRMD (46 out of 100)

Stock Price Rating (Max of 10) 9
Historical Stock Price Rating (Max of 10) 7
Stock Price Trend (Max of 10) 10
Book Value (Max of 10) 4
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 3
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 1
Operating Margin (Max of 10) 6
Trading Volume (Max of 10) 4
Price to Earnings (Max of 10) 2
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for IRMD

IRadimed (IRMD) Q2 2026 Earnings Call Transcript 8/9/2026 11:41:00 PM
iRadimed (NASDAQ:IRMD) Cut to "Hold" at Wall Street Zen 8/8/2026 10:18:00 AM
IRadimed (IRMD) Q2 2026 Earnings Call Transcript 8/8/2026 3:10:00 AM
IRADIMED (IRMD) Stock Drops As 3870 Ramp Cuts Gross Margin 8/3/2026 3:43:00 AM
IRADIMED CORP Q2 2026: Revenue $20.47M, EPS $0.41— 10-Q Summary 7/31/2026 8:10:00 PM
IRadimed: Q2 Earnings Snapshot 7/31/2026 12:10:00 PM
IRADIMED: More Than 70% of New Pump Orders Were Four-Pump Setups 7/31/2026 12:10:00 PM
Iradimed reports Q2 revenue $20.5M, EPS $0.41; raises dividend to $0.20 and reaffirms 2026 guidance 7/31/2026 12:10:00 PM
IRadimed: Q2 Earnings Snapshot 7/31/2026 7:23:00 AM
Iradimed earnings on deck as growth momentum faces Q2 test 7/30/2026 6:09:00 PM

Financial Details for IRMD

Company Overview

Ticker IRMD
Company Name Iradimed Corp
Country USA
Description IRADIMED CORPORATION develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories and services in the United States and internationally. The company is headquartered in Winter Springs, Florida.
Sector Name HEALTHCARE
Industry Name MEDICAL DEVICES
Most Recent Quarter 6/30/2026
Next Earnings Date N/A

Stock Price History

Last Day Price 90.27
Price 4 Years Ago 26.31
Last Day Price Updated 8/11/2026 1:48:59 PM EST
Last Day Volume 178,112
Average Daily Volume 130,912
52-Week High 107.44
52-Week Low 67.07
Last Price to 52 Week Low 34.59%

Valuation Measures

Trailing PE 50.43
Industry PE 93.59
Sector PE 49.78
5-Year Average PE 49.07
Free Cash Flow Ratio 19.54
Industry Free Cash Flow Ratio 39.89
Sector Free Cash Flow Ratio 109.34
Current Ratio Most Recent Quarter 9.46
Total Cash Per Share 4.62
Book Value Per Share Most Recent Quarter 7.96
Price to Book Ratio 11.63
Industry Price to Book Ratio 4.32
Sector Price to Book Ratio 8.84
Price to Sales Ratio Twelve Trailing Months 13.37
Industry Price to Sales Ratio Twelve Trailing Months 3.45
Sector Price to Sales Ratio Twelve Trailing Months 24.40
Analyst Buy Ratings 2
Analyst Strong Buy Ratings 0

Share Statistics

Total Shares Outstanding 12,787,000
Market Capitalization 1,154,282,490
Institutional Ownership 61.16%

Dividends

Ex-Dividend Date 8/14/2026
Previous Dividend Amount 0.2000
Current Dividend Amount 0.2000
Total Years Dividend Increasing 3
Trailing Annual Dividend Rate 1.07
Trailing Annual Dividend Yield 1.19%
Forward Annual Dividend Rate 0.80
Forward Annual Dividend Yield 0.89%
5-Year Dividend Payments Count 15
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio 59.78%

Income Statement

Quarterly Earnings Growth YOY -9.30%
Annual Earnings Growth 16.88%
Reported EPS 12 Trailing Months 1.79
Reported EPS Past Year 0.90
Reported EPS Prior Year 1.92
Net Income Twelve Trailing Months 23,054,652
Net Income Past Year 22,480,000
Net Income Prior Year 19,234,026
Quarterly Revenue Growth YOY 0.30%
5-Year Revenue Growth 21.45%
Operating Margin Twelve Trailing Months 31.20%

Balance Sheet

Total Cash Most Recent Quarter 59,080,000
Total Cash Past Year 51,159,000
Total Cash Prior Year 52,233,907
Net Cash Position Most Recent Quarter 59,080,000
Net Cash Position Past Year 51,159,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 94,618,000
Total Stockholder Equity Prior Year 86,818,756
Total Stockholder Equity Most Recent Quarter 101,748,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 24,930,866
Free Cash Flow Per Share Twelve Trailing Months 1.95
Free Cash Flow Past Year 17,182,000
Free Cash Flow Prior Year 17,619,430

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating None

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.00
MACD Signal 0.00
20-Day Bollinger Lower Band 0.00
20-Day Bollinger Middle Band 0.00
20-Day Bollinger Upper Band 0.00
Beta 0.91
RSI 0.00
50-Day SMA 0.00
150-Day SMA 0.00
200-Day SMA 56.10

System

Modified 8/11/2026 9:16:30 PM EST